← Back to Clinical Trials
Recruiting NCT06185244

NCT06185244 Efficacy of Internet-delivered Trauma-focused CBT for Young People With PTSD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06185244
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Posttraumatic Stress Disorder
Study Type INTERVENTIONAL
Enrollment 240 participants
Start Date 2024-03-11
Primary Completion 2027-01-04

Trial Parameters

Condition Posttraumatic Stress Disorder
Sponsor Karolinska Institutet
Study Type INTERVENTIONAL
Phase N/A
Enrollment 240
Sex ALL
Min Age 13 Years
Max Age 17 Years
Start Date 2024-03-11
Completion 2027-01-04
Interventions
Therapist-supported internet-delivered trauma-focused CBT12 weeks of therapist-supported internet-delivered psychoeducation and stress management/relaxation for both the youth and the care giver.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to compare therapist-guided internet delivered trauma-focused cognitive behavior therapy (CBT) to an active control condition comprising therapist-guided internet delivered cognitive behavioral therapy containing relaxation techniques and psychoeducation for young people with post-traumatic stress disorder regarding efficacy and cost effectiveness. Young people with post-traumatic stress disorder will be randomly assigned to receive either 12 weeks of therapist-guided internet delivered trauma-focused cognitive behavior therapy (iTF-CBT) or therapist-guided internet delivered cognitive-behavioral therapy containing relaxation and psychoeducation.

Eligibility Criteria

Inclusion Criteria: * 13-17 years, * Primary PTSD diagnosis * Fluent in Swedish * Access to the Internet at home or can use vouchers for internet-access to their phone. * Parent/guardian willing and able to take part in treatment. Exclusion Criteria: * PTSD is not the primary concern * Initiation or adjustment of any psychotropic medication within the last 4 weeks prior to commencement of treatment * Serious mental health symptoms, such as mania, psychosis, alcohol, or substance use disorders or current suicide risk warranting immediate clinical attention. * Ongoing trauma-focused CBT or Eye movement desensitization and reprocessing Therapy * Ongoing trauma-related threat

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology